DEXCOM INC (DXCM) Deferred Tax Assets, Valuation Allowance USD 2010 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Dexcom Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2010 to 2023.
  • Dexcom Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $264 M, a 236% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $264 M +$186 M +236% Dec 31, 2023 10-K 2024-02-08
Q4 2022 $78.7 M +$8.8 M +12.6% Dec 31, 2022 10-K 2024-02-08
Q4 2021 $69.9 M +$14.4 M +25.9% Dec 31, 2021 10-K 2023-02-09
Q4 2020 $55.5 M -$277 M -83.3% Dec 31, 2020 10-K 2022-02-14
Q4 2019 $332 M +$2.1 M +0.64% Dec 31, 2019 10-K 2021-02-11
Q4 2018 $330 M +$66.6 M +25.3% Dec 31, 2018 10-K 2020-02-13
Q4 2017 $264 M +$70.1 M +36.2% Dec 31, 2017 10-K 2019-02-21
Q4 2016 $193 M -$3 M -1.53% Dec 31, 2016 10-K 2018-02-27
Q4 2015 $196 M +$27.4 M +16.2% Dec 31, 2015 10-K 2017-02-28
Q4 2014 $169 M +$4.3 M +2.61% Dec 31, 2014 10-K 2016-02-23
Q4 2013 $165 M +$13.4 M +8.86% Dec 31, 2013 10-K 2015-02-25
Q4 2012 $151 M +$16.6 M +12.3% Dec 31, 2012 10-K 2014-02-20
Q4 2011 $135 M +$16.4 M +13.9% Dec 31, 2011 10-K 2013-02-21
Q4 2010 $118 M Dec 31, 2010 10-K 2012-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.